Jeffrey Tharp

Avicanna is a life sciences company focused on advancement and commercialization of evidence-based cannabinoid products for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform including R&D & clinical development that has led to the commercialization of 30+ products across various market segments: • Medical Cannabis & Wellness Products (RHO Phyto™): The formulary offers a diverse range of proprietary formulations including oral, sublingual, topical, & transdermal deliveries with varying ratios of cannabinoids and is supported with ongoing patient, and medical community education. RHO Phyto is a leading medical brand in Canada and is currently available nationwide to patients across several medical channels and continues to expand into new international markets. • Pharmaceutical Preparations and Pipeline: Leveraging Avicanna’s scientific platform, vertical integration, and real-world evidence, Avicanna has an extensive pipeline of indication-specific, patent-pending drug candidates in various stages of clinical development and commercialization. These drug candidates aim to address unmet medical needs in dermatology, chronic pain, and various neurological disorders. Avicanna’s first pharmaceutical preparation (Trunerox™) is approved in Colombia and is in registration in other South American markets. • MyMedi.ca Medical Cannabis Care: MyMedi.ca is a medical cannabis care platform formed with the aim to better serve medical cannabis patients’ needs and enhance the patient journey. MyMedi.ca is operated by Northern Green Canada Inc., and features a diverse portfolio of products and pharmacist-led patient support programs. It also provides specialty services to distinct patient groups such as veterans and collaborates with public and private providers for adjudication and reimbursement. MyMedi.ca provides educational resources to facilitate the incorporation of medical cannabis into health care regimens.

Authorized Licensed Producers under the MMPR. THC BioMed is an organization strategically located in beautiful Kelowna, BC that is devoted to Research & Development, plant innovation and life sciences, with the emphasis on Medical Cannabis.

Since our founding in 2013, Maricann Inc. has been driven by a combination of passion, dedication and expertise. Maricann is built on years of experience in the cannabis industry. We offer products such as dried flower and cannabis oil. Great importance is placed on quality assurance for all our production processes, in accordance with GMP regulations, which ensure high quality and standardized products. As a vertically integrated cultivator and processor of cannabis, we strive to be on the cutting edge of cannabis innovation. Our production facilities are based in Ontario, Canada, where we operate a cannabis cultivation, processing and distribution business under Health Canada federal license. Traditions, values, environmental consciousness and stakeholder responsibility matter greatly to us. We operate in a pro-active, ground-breaking and forward-looking manner while also placing great emphasis on a responsible and meaningful use of resources. We profoundly believe in the world’s oldest cultivated plant and therefore continuously strive to enhance the lives of our consumers through our cannabis products. Maricann is a portfolio company of Ring International Holding AG (RIH), a multi-award winning, family-owned industrial group founded in 2001. RIHs headquarters are situated in Vienna, Austria from where it operates subsidiaries in Europe, Asia and North America. RIH is one of Austrias most dynamic industrial groups focusing on actively developing companies in strategically selected industries. As such, Maricann now forms part of a group of peer companies in RIH’s cannabis division.

Aurora Cannabis Inc. is a world-renowned integrated cannabis company with an industry-leading reputation for continuously elevating and setting the global cannabis industry standard. Through our wholly owned subsidiaries, strategic investments, and global partnerships, Aurora provides a wide range of premium quality cannabis and hemp products and services, develops innovative technologies, promotes cannabis consumer health and wellness, and delivers an exceptional customer experience across all its brands. Aurora’s operations span multiple continents and focuses on both the medical and recreational cannabis production and sales, patient education and clinic counselling services, home hydroponic cultivation, extraction technologies and delivery systems, and hemp-based food health products. We operate around the globe pursuing new and emerging cannabis markets where possible through our owned network of import, export and wholesale distributors, and our e-commerce and mobile applications.

MediPharm Labs was created in 2015 by a handful of industry experts in Ontario. With the medicinal benefits of cannabis firmly established – and with a global patient market demanding quality cannabis oil – MediPharm Labs was born. While initially exploring options to cultivate cannabis plant, MediPharm Labs came to recognize the opportunity for a select focus on cannabis concentrates. MediPharm Labs set out to master this area of production, and rely on the many cultivating experts to provide quality raw materials. In 2016, MediPharm labs submitted an application to Health Canada for approval to distribute medicinal cannabis oil. Proudly, MediPharm Labs was one of the first Licensed Producer applications in history to apply for license that did not include the cultivation of cannabis. The key to MediPharm Labs’ unrivaled quality is our best possible use of modern technology and innovative extraction techniques. MediPharm Labs produces cannabis oil that is pharmaceutical grade and and meets the specific quality and purity requirements. The team behind MediPharm Labs have proven industry experience in the areas of pharmaceutical extraction, processing and quality assurance. In 2018, MediPharm Labs is gearing up to commence distribution to our Health Canada approved business partners and make history. The response has been enormous, positive and heartening. Medicinal cannabis has arrived – and through our partners we will provide patients with access to pure, consistent and safe cannabis oil. MediPharm Labs commenced construction of a world-class extraction facility in Australia in June 2018. MediPharm Labs Australia is a subsidiary of MediPharm Labs Inc. and the companies’ first expansion outside of Canada. MediPharm Labs Australia completed its application process with the federal Office of Drug Control in February 2018 to extract and import medical cannabis products in Australia. For media and investor relations, please email: info@medipharmlabs.com

Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy, wellness and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

Charles Schwab is a different kind of investment services firm – one that strives to disrupt the status quo of the traditional Wall Street approach on behalf of our clients. We believe today, as we did on Day 1, that when you find ways to improve the investing experience for your clients, then business results will follow. Follow our company culture at #SchwabLife and see how we give back at #Schwab4Good. Support hours: 7 a.m.–7 p.m. CT or 24/7 at schwab.com/contact-us. Social Media Disclosures: https://www.aboutschwab.com/social-media (#0424-TM8W)

Avicanna is a life sciences company focused on advancement and commercialization of evidence-based cannabinoid products for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform including R&D & clinical development that has led to the commercialization of 30+ products across various market segments: • Medical Cannabis & Wellness Products (RHO Phyto™): The formulary offers a diverse range of proprietary formulations including oral, sublingual, topical, & transdermal deliveries with varying ratios of cannabinoids and is supported with ongoing patient, and medical community education. RHO Phyto is a leading medical brand in Canada and is currently available nationwide to patients across several medical channels and continues to expand into new international markets. • Pharmaceutical Preparations and Pipeline: Leveraging Avicanna’s scientific platform, vertical integration, and real-world evidence, Avicanna has an extensive pipeline of indication-specific, patent-pending drug candidates in various stages of clinical development and commercialization. These drug candidates aim to address unmet medical needs in dermatology, chronic pain, and various neurological disorders. Avicanna’s first pharmaceutical preparation (Trunerox™) is approved in Colombia and is in registration in other South American markets. • MyMedi.ca Medical Cannabis Care: MyMedi.ca is a medical cannabis care platform formed with the aim to better serve medical cannabis patients’ needs and enhance the patient journey. MyMedi.ca is operated by Northern Green Canada Inc., and features a diverse portfolio of products and pharmacist-led patient support programs. It also provides specialty services to distinct patient groups such as veterans and collaborates with public and private providers for adjudication and reimbursement. MyMedi.ca provides educational resources to facilitate the incorporation of medical cannabis into health care regimens.

Authorized Licensed Producers under the MMPR. THC BioMed is an organization strategically located in beautiful Kelowna, BC that is devoted to Research & Development, plant innovation and life sciences, with the emphasis on Medical Cannabis.

Since our founding in 2013, Maricann Inc. has been driven by a combination of passion, dedication and expertise. Maricann is built on years of experience in the cannabis industry. We offer products such as dried flower and cannabis oil. Great importance is placed on quality assurance for all our production processes, in accordance with GMP regulations, which ensure high quality and standardized products. As a vertically integrated cultivator and processor of cannabis, we strive to be on the cutting edge of cannabis innovation. Our production facilities are based in Ontario, Canada, where we operate a cannabis cultivation, processing and distribution business under Health Canada federal license. Traditions, values, environmental consciousness and stakeholder responsibility matter greatly to us. We operate in a pro-active, ground-breaking and forward-looking manner while also placing great emphasis on a responsible and meaningful use of resources. We profoundly believe in the world’s oldest cultivated plant and therefore continuously strive to enhance the lives of our consumers through our cannabis products. Maricann is a portfolio company of Ring International Holding AG (RIH), a multi-award winning, family-owned industrial group founded in 2001. RIHs headquarters are situated in Vienna, Austria from where it operates subsidiaries in Europe, Asia and North America. RIH is one of Austrias most dynamic industrial groups focusing on actively developing companies in strategically selected industries. As such, Maricann now forms part of a group of peer companies in RIH’s cannabis division.

Aurora Cannabis Inc. is a world-renowned integrated cannabis company with an industry-leading reputation for continuously elevating and setting the global cannabis industry standard. Through our wholly owned subsidiaries, strategic investments, and global partnerships, Aurora provides a wide range of premium quality cannabis and hemp products and services, develops innovative technologies, promotes cannabis consumer health and wellness, and delivers an exceptional customer experience across all its brands. Aurora’s operations span multiple continents and focuses on both the medical and recreational cannabis production and sales, patient education and clinic counselling services, home hydroponic cultivation, extraction technologies and delivery systems, and hemp-based food health products. We operate around the globe pursuing new and emerging cannabis markets where possible through our owned network of import, export and wholesale distributors, and our e-commerce and mobile applications.

MediPharm Labs was created in 2015 by a handful of industry experts in Ontario. With the medicinal benefits of cannabis firmly established – and with a global patient market demanding quality cannabis oil – MediPharm Labs was born. While initially exploring options to cultivate cannabis plant, MediPharm Labs came to recognize the opportunity for a select focus on cannabis concentrates. MediPharm Labs set out to master this area of production, and rely on the many cultivating experts to provide quality raw materials. In 2016, MediPharm labs submitted an application to Health Canada for approval to distribute medicinal cannabis oil. Proudly, MediPharm Labs was one of the first Licensed Producer applications in history to apply for license that did not include the cultivation of cannabis. The key to MediPharm Labs’ unrivaled quality is our best possible use of modern technology and innovative extraction techniques. MediPharm Labs produces cannabis oil that is pharmaceutical grade and and meets the specific quality and purity requirements. The team behind MediPharm Labs have proven industry experience in the areas of pharmaceutical extraction, processing and quality assurance. In 2018, MediPharm Labs is gearing up to commence distribution to our Health Canada approved business partners and make history. The response has been enormous, positive and heartening. Medicinal cannabis has arrived – and through our partners we will provide patients with access to pure, consistent and safe cannabis oil. MediPharm Labs commenced construction of a world-class extraction facility in Australia in June 2018. MediPharm Labs Australia is a subsidiary of MediPharm Labs Inc. and the companies’ first expansion outside of Canada. MediPharm Labs Australia completed its application process with the federal Office of Drug Control in February 2018 to extract and import medical cannabis products in Australia. For media and investor relations, please email: info@medipharmlabs.com